Synthesis and single-crystal characterization of novel 2-ferrocenyl-4H-pyrazolo[5,1-c][1,4]oxazin-4-one derivatives

被引：12

作者：

Xie, Yong-Sheng ^{[1
]}

Zhao, Bao-Xiang ^{[1
]}

Lv, Hong-Shui ^{[1
]}

Li, Ji-Kun ^{[2
]}

Wang, Bai-Shan ^{[1
]}

Shin, Dong-Soo ^{[3
]}

机构：

[1] Shandong Univ, Inst Organ Chem, Sch Chem & Chem Engn, Jinan 250100, Peoples R China

[2] Taishan Univ, Dept Mat Sci & Chem Engn, Tai An 271021, Shandong, Peoples R China

[3] Changwon Natl Univ, Dept Chem, Chang Won 641773, South Korea

来源：

JOURNAL OF MOLECULAR STRUCTURE | 2009年 / 930卷 / 1-3期

关键词：

Ferrocene; Pyrazole-fused oxazinone; Synthesis; X-ray structure; COAGULATION-FACTOR XA; ESTROGEN-RECEPTOR MODULATORS; PRELIMINARY BIOLOGICAL EVALUATION; ORALLY BIOAVAILABLE INHIBITOR; PYRAZIN-4(5H)-ONE DERIVATIVES; FERROCENYL PYRAZOLES; BREAST-CANCER; HIGHLY POTENT; AGENTS; SERMS;

D O I：

10.1016/j.molstruc.2009.04.042

中图分类号：

O64 [物理化学（理论化学）、化学物理学];

学科分类号：

070304 ; 081704 ;

摘要：

A series of novel 2-ferrocenyl-6-substituted-4H-pyrazolo[5,1-c][1,4]oxazin-4-one derivatives were synthesized by the intra-esterification reaction of ethyl 1-(2-aryl-2-oxoethyl)-3-ferrocenyl-1H-pyrazole-5-carboxylate in the presence of magnesium bromide and diisopropylethylamine in one-pot procedure. The structures of compounds were characterized by H-1 NMR, C-13 NMR, IR, HRMS and X-ray diffraction analysis. (C) 2009 Elsevier B.V. All rights reserved.

引用

页码：83 / 87

页数：5

共 37 条

[21] 5-Alkyl-2-ferrocenyl-6,7-dihydropyrazolo[1,5-a] pyrazin-4(5H)-one derivatives inhibit growth of lung cancer A549 cell by inducing apoptosis [J].

Pan, Xiao-Hong ;

Liu, Xia ;

Zhao, Bao-Xiang ;

Xie, Yong-Sheng ;

Shin, Dong-Soo ;

Zhang, Shang-Li ;

Zhao, Jing ;

Miao, Jun-Ying .

BIOORGANIC & MEDICINAL CHEMISTRY, 2008, 16 (20) :9093-9100

[22] Synthesis and structure-activity relationships of the first ferrocenyl-aryl-hydantoin derivatives of the nonsteroidal antiandrogen nilutamide [J].

Payen, Olivier ;

Top, Siden ;

Vessieres, Anne ;

Brule, Emilie ;

Plamont, Marie-Aude ;

McGlinchey, Michael J. ;

Mueller-Bunz, Helge ;

Jaouen, Gerard .

JOURNAL OF MEDICINAL CHEMISTRY, 2008, 51 (06) :1791-1799

[23] Discovery of 1-(4-methoxyphenyl)-7-oxo-6-(4-(2-oxopiperidin-1-yl)phenyl)-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxamide (apixaban, BMS-562247), a highly potent, selective, efficacious, and orally bioavailable inhibitor of blood coagulation factor Xa [J].

Pinto, Donald J. P. ;

Orwat, Michael J. ;

Koch, Stephanie ;

Rossi, Karen A. ;

Alexander, Richard S. ;

Smallwood, Angela ;

Wong, Pancras C. ;

Rendina, Alan R. ;

Luettgen, Joseph M. ;

Knabb, Robert M. ;

He, Kan ;

Xin, Baomin ;

Wexler, Ruth R. ;

Lam, Patrick Y. S. .

JOURNAL OF MEDICINAL CHEMISTRY, 2007, 50 (22) :5339-5356

[24] 1-[3-aminobenzisoxazol-5′-yl]-3-trifluoromethyl-6-12′-(3-(R)-hydroxy-N-pyrrolidinyl)methyl-[1,1′]-biphen-4-yl]-1,4,5,6-tetrahydropyrazolo-13,4-c]-pyridin-7-one (BMS-740808) a highly potent, selective, efficacious, and orally bioavailable inhibitor of blood coagulation factor Xa 10.1016/j.bmel.2006.02.069 [J].

Pinto, Donald J. P. ;

Orwat, Michael J. ;

Quan, Mimi L. ;

Han, Qi ;

Galemmo, Robert A., Jr. ;

Amparo, Eugene ;

Wells, Brian ;

Ellis, Christopher ;

He, Ming Y. ;

Alexander, Richard S. ;

Rossi, Karen A. ;

Smallwood, Angela ;

Wong, Pancras C. ;

Luettgen, Joseph M. ;

Rendina, Alan R. ;

Knabb, Robert M. ;

Mersinger, Lawrence ;

Kettner, Charles ;

Bal, Steven ;

He, Kan ;

Wexler, Ruth R. ;

Lam, Patrick Y. S. .

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2006, 16 (15) :4141-4147

[25] Synthesis, cannabinoid receptor affinity, and molecular modeling studies of substituted 1-aryl-5-(1H-pyrrol-1-yl)-1H-pyrazole-3-carboxamides [J].

Silvestri, Romano ;

Cascio, Maria Grazia ;

La Regina, Giuseppe ;

Piscitelli, Francesco ;

Lavecchia, Antonio ;

Brizzi, Antonella ;

Pasquini, Serena ;

Botta, Maurizio ;

Novellino, Ettore ;

Di Marzo, Vincenzo ;

Corelli, Federico .

JOURNAL OF MEDICINAL CHEMISTRY, 2008, 51 (06) :1560-1576

[26]

Sun HK, 2002, J ORGANOMET CHEM, V655, P182

[27] New celecoxib derivatives as anti-inflammatory agents [J].

Szabo, Gyoergy ;

Fischer, Janos ;

Kis-Varga, Agnes ;

Gyires, Klara .

JOURNAL OF MEDICINAL CHEMISTRY, 2008, 51 (01) :142-147

[28] Facile route to ferrocifen, 1-[4-(2-dimethylaminoethoxy)]-1-(phenyl-2-ferrocenyl-but-1-ene), first organometallic analogue of tamoxifen, by the McMurry reaction [J].

Top, S ;

Dauer, B ;

Vaissermann, J ;

Jaouen, G .

JOURNAL OF ORGANOMETALLIC CHEMISTRY, 1997, 541 (1-2) :355-361

[29] Synthesis, biochemical properties and molecular modelling studies of organometallic specific estrogen receptor modulators (SERMs), the ferrocifens and hydroxyferrocifens:: Evidence for an antiproliferative effect of hydroxyferrocifens on both hormone-dependent and hormone-independent breast cancer cell lines [J].

Top, S ;

Vessières, A ;

Leclercq, G ;

Quivy, J ;

Tang, J ;

Vaissermann, J ;

Huché, M ;

Jaouen, G .

CHEMISTRY-A EUROPEAN JOURNAL, 2003, 9 (21) :5223-5236

[30] Studies on organometallic selective estrogen receptor modulators.: (SERMs) Dual activity in the hydroxy-ferrocifen series [J].

Top, S ;

Vessières, A ;

Cabestaing, C ;

Laios, I ;

Leclercq, G ;

Provot, C ;

Jaouen, G .

JOURNAL OF ORGANOMETALLIC CHEMISTRY, 2001, 637 :500-506

← 1 2 3 4 →